Akari Therapeutics Plc logo

Akari Therapeutics Plc share price today

(AKTX)

Akari Therapeutics Plc share price is $0.97 & ₹82.43 as on 21 Dec 2024, 2.30 'hrs' IST

$0.97

-0.03

(-2.99%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Akari Therapeutics Plc share price in Dollar and Rupees. Guide to invest in Akari Therapeutics Plc from India. Also see the sentimental analysis on Indian investors investing in Akari Therapeutics Plc. Get details on the Indian mutual funds that are investing in Akari Therapeutics Plc. Get Analyst recommendations and forecasts along with all the Akari Therapeutics Plc's financials.

Akari Therapeutics Plc share price movements

  • Today's Low: $0.95
    Today's High: $1.01

    Day's Volatility :6.29%

  • 52 Weeks Low: $0.90
    52 Weeks High: $4.40

    52 Weeks Volatility :79.55%

Akari Therapeutics Plc Returns

PeriodAkari Therapeutics PlcIndex (Russel 2000)
3 Months
-69.69%
0.0%
6 Months
-73.5%
0.0%
1 Year
-67.77%
0.0%
3 Years
-96.85%
-19.7%

Akari Therapeutics Plc Key Statistics

in dollars & INR

Previous Close
$0.9999
Open
$0.976
Today's High
$1.0138
Today's Low
$0.95
Market Capitalization
$30.3M
Today's Volume
$36.8K
52 Week High
$4.4
52 Week Low
$0.9
Revenue TTM
$0.0
EBITDA
$-18.1M
Earnings Per Share (EPS)
$-2.58
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1281.43%

How to invest in Akari Therapeutics Plc from India?

It is very easy for Indian residents to invest directly in Akari Therapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Akari Therapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Akari Therapeutics Plc or AKTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Akari Therapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Akari Therapeutics Plc shares which would translate to 0.876 fractional shares of Akari Therapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Akari Therapeutics Plc, in just a few clicks!

Returns in Akari Therapeutics Plc for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Akari Therapeutics Plc investment value today

Current value as on today

₹1,69,970

Returns

₹69,970

(+69.97%)

Returns from Akari Therapeutics Plc Stock

₹67,774 (false-67.77%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Akari Therapeutics Plc

16.67%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Investment in Akari Therapeutics Plc from India has grown in the last 30 days as on Dec 22, 2024. 16.67% more purchase transactions for Akari Therapeutics Plc in the last 30 days versus the previous period.

127%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Akari Therapeutics Plc on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 127% more investors are searching Akari Therapeutics Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Akari Therapeutics Plc

  • Omnia Family Wealth, LLC

    0.35%

  • Citadel Advisors Llc

    0.13%

  • HPM Partners LLC

    0.10%

  • Cresset Asset Management, LLC

    0.07%

  • Renaissance Technologies Corp

    0.07%

Analyst Recommendation on Akari Therapeutics Plc

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Akari Therapeutics Plc(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Akari Therapeutics Plc

What analysts predicted

Upside of 8147.42%

Current:

$0.97

Target:

$80.00

Insights on Akari Therapeutics Plc

  • Price Movement

    In the last 1 month, AKTX stock has moved down by -21.8%
  • AKTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 103.7%
  • AKTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 119.8%

Akari Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Akari Therapeutics Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Akari Therapeutics Plc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Akari Therapeutics Plc
-25.38%
-73.5%
-67.77%
-96.85%
-97.23%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Akari Therapeutics Plc
NA
NA
0.0
0.0
-12.81
-1.73
NA
-0.04
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Akari Therapeutics Plc
Buy
$30.3M
-97.23%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

About Akari Therapeutics Plc

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Organization
Akari Therapeutics Plc
Employees
6
CEO
Dr. Samir Rashmikant Patel M.D.
Industry
Health Technology

Management People of Akari Therapeutics Plc

NameTitle
Dr. Samir Rashmikant Patel M.D.
Interim President, CEO & Director
Ms. Wendy F. DiCicco CPA
Interim Chief Financial Officer
Dr. Miles Nunn
Chief Scientific Officer

Important FAQs about investing in Akari Therapeutics Plc from India :

What is Akari Therapeutics Plc share price today?

Akari Therapeutics Plc share price today stands at $0.97, Open: $0.98 ; Previous Close: $1.00 ; High: $1.01 ; Low: $0.95 ; 52 Week High: $4.40 ; 52 Week Low: $0.90. The stock opens at $0.98, after a previous close of $1.00. The stock reached a daily high of $1.01 and a low of $0.95, with a 52-week high of $4.40 and a 52-week low of $0.90.

Can Indians buy Akari Therapeutics Plc shares?

Yes, Indians can invest in the Akari Therapeutics Plc (AKTX) from India.

With INDmoney, you can buy Akari Therapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Akari Therapeutics Plc at zero transaction cost.

How can I buy Akari Therapeutics Plc shares from India?

It is very easy to buy Akari Therapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Akari Therapeutics Plc be purchased?

Yes, you can buy fractional shares of Akari Therapeutics Plc with INDmoney app.

What are the documents required to start investing in Akari Therapeutics Plc stocks?

To start investing in Akari Therapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Akari Therapeutics Plc

Today’s highest price of Akari Therapeutics Plc (AKTX) is $1.01.

Today’s lowest price of Akari Therapeutics Plc (AKTX) is $0.95.

What is today's market capitalisation of Akari Therapeutics Plc

Today's market capitalisation of Akari Therapeutics Plc AKTX is 30.3M

What is the 52 Week High and Low Range of Akari Therapeutics Plc

  • 52 Week High

    $4.40

  • 52 Week Low

    $0.90

What are the historical returns of Akari Therapeutics Plc?

  • 1 Month Returns

    -25.38%

  • 3 Months Returns

    -73.5%

  • 1 Year Returns

    -67.77%

  • 5 Years Returns

    -97.23%

Who is the Chief Executive Officer (CEO) of Akari Therapeutics Plc

Dr. Samir Rashmikant Patel M.D. is the current Chief Executive Officer (CEO) of Akari Therapeutics Plc.